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Multiplex qRT-PCR
Data-driven normalizationAdvances in multiplex qRT-PCR have enabled increasingly accurate and robust quantiﬁcation of RNA,
even at lower concentrations, facilitating RNA expression proﬁling in clinical and environmental samples.
Here we describe a data-driven qRT-PCR normalization method, the minimum variance method, and
evaluate it on clinically derived Mycobacterium tuberculosis samples with variable transcript detection
percentages. For moderate to signiﬁcant amounts of nondetection (50%), our minimum variance
method consistently produces the lowest false discovery rates compared to commonly used data-driven
normalization methods.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Accurate quantiﬁcation of very low concentrations of RNA via
multiplex qRT-PCR1 has enabled large-scale RNA expression proﬁling
beyond the traditional laboratory settings, including the longitudinal
analysis of clinical, pathogen, and environmentally derived samples.
Data normalization in these types of samples poses three major chal-
lenges not typically encountered in carefully controlled laboratory
experiments: (1) the absenceof validatedendogenous reference genes
(housekeeping genes), (2)marked variation in the abundance of target
material, and (3) differences between the reference sample and the
test sample (between-sample variability) in the number of detectable
transcripts, particularly in samples with low abundance of target
material. As such, these studies are often normalized using data-
driven methods, but between-sample variability in the number of
nondetectable transcripts (i.e., missing transcripts) may bias these
data-driven normalizations, potentially leading to false discovery.
Nondetected transcripts, deﬁned as transcripts with a zero or
very low abundance as evaluated by a qRT-PCR threshold, mayresult from two experimentally indistinguishable possibilities: a
biological state in which a gene is not transcribed (true negative
result), or conversely, an experimental error in which a gene is
transcribed but not detected (false negative result) due to the
detection limits of the assay. False negative results increase as
the abundance of target material decreases and low-concentration
transcripts can no longer be ampliﬁed efﬁciently.
In our own work, we have encountered these challenges in the
global analysis of Mycobacterium tuberculosis (Mtb) gene expres-
sion proﬁles from pathogen RNA derived from the sputum of
patients treated for tuberculosis (TB). We observed that as antibi-
otic treatment kills the bacteria, the burden of live Mtb decreases,
and therefore the number of transcripts detected declines progres-
sively during longitudinal treatment.
In this paper, we systematically evaluate data-driven normaliza-
tion methods, and introduce a novel method—minimum variance
normalization—designed for datawithvariable transcript nondetec-
tion. We ﬁrst discuss circumstances in which standard reference-
basednormalizations are inadequateanddata-drivennormalization
may be preferable. Using an experimental dilution series of mRNA
derived from TB patient samples to simulate decreasing abundance
of input targetmaterial and increasing proportions of nondetection,
we evaluate three existing data-driven normalization methods
Fig.1. Simulating effects of low abundance on nonrandom nondetection of
transcripts using serial dilution experiments. Each point represents a detected
transcript in the dilution with the cycle threshold (CT) value coming from the
undiluted sample. Distributions become more divergent for greater CT values
making quantile-based approaches unreliable.
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method. To identify whether bias resulting from between-sample
variability in transcript nondetection leads to increased false discov-
ery rates, we compare the proportion of genes erroneously classiﬁed
as differentially expressed with all four methods.
The most commonly used method for normalizing qRT-PCR
analysis in laboratory-based and controlled environments is the
identiﬁcation of a set of housekeeping genes whose expression is
demonstrated or hypothesized to be invariant, relative to all other
genes under the conditions being studied [1]. Expression is
reported as a ratio relative to the expression of the set of reference
genes in that sample. Experimental validation of stable expression
of housekeeping genes is imperative, since choosing the wrong
housekeeping genes for normalization may lead to erroneous con-
clusions [2–4].
Unfortunately, experimental validation of reference genes for
normalization is frequently not possible for complex samples such
as human clinical specimens, particularly those collected in obser-
vational ﬁeld settings. In our study of Mtb expression, for example,
bacterial phenotypes and sputum conditions change substantially
with increasing duration of antibiotic treatment, transitioning
from unencumbered bacterial growth prior to antibiotic initiation
to rapid killing in the early days of treatment, to an antibiotic-
tolerant ‘‘persister’’ bacterial state as therapy progresses [5].
We considered whether other sample characteristics—including
sputum volume, quantitative culture, or nucleic acid abundance—
might provide an alternative reference for normalization; an ideal
measure would enumerate viable bacteria present. Unfortunately,
no optimal sample-based referent was identiﬁed. Sputum sample
volume is difﬁcult to measure and does not directly correlate with
bacterial burden. Culture fails to enumerate viable but noncultur-
able bacilli, which may be transcriptionally active. Quantity of
Mtb DNA does not measure viable bacteria since DNA from killed
Mtb has a long half-life in sputum [6]. Ribosomal RNA subunits
appear to be regulated by antibiotic exposure [7] and are therefore
not a stable reference.
One alternative to using the sample-speciﬁc endogenous con-
trols is to normalize to an exogenous control (spike-in) transcript
of known quantity that is not present in the sample of interest.
Exogenous controls enable adjustment for variability in PCR
quantiﬁcation [3]; however, since they are added after initial sample
processing, they cannot control for variation in input biological
material, which is frequently a central challenge in complex
samples.
Data-driven normalization is fundamentally different than
normalization to endogenous or exogenous controls. Data-driven
methods assume that mathematical or statistical properties of the
data itself (such as the mean, median, quantiles, or variance) are
invariant across samples and conditions. These properties are used
as a reference to make the overall signal distribution of samples as
similar to one another as possible. Long standard in analysis of cDNA
microarrays [8,9], data-driven normalization methods have been
adapted for PCR because multiplex platforms can simplify quantiﬁ-
cation of hundreds or thousands of transcripts [10]. Although data-
driven normalization methods have been widely adopted [3,10],
there has been insufﬁcient attention paid to determining if
between-sample variability in the proportion of nondetectable
transcripts can bias data-driven normalization methods, leading
to false discovery and false inference of differential expression.
We compared data-driven normalization methods in dilution
experiments designed to simulate the progressive increase in non-
detection of low-abundance transcripts that often occurs as the
abundance of target RNA decreases. Since there are no true biolog-
ical differences between our dilutions, any transcripts signiﬁcantly
differentially expressed in the comparison between dilutions rep-
resent false discoveries, which we can use to evaluate methods.In order to evaluate data-driven normalizationmethods we per-
formed dilution experiments followed by the implementation of
three commonly used data-driven methods and a novel alternative
method, the minimum variance method, designed to minimize
false discovery in such datasets. We compared false discovery rates
among these different normalization methods, at different levels of
transcript nondetection.
Using the PCR platform described in the Supplemental methods,
we quantiﬁed expression of 768 Mtb genes from sputum samples
collected from two TB patients prior to antibiotic treatment. Three
technical replicates were performed each at 10- and 100-fold
dilutions, and six replicates were performed each at 1000- and
10,000-fold dilutions.
As expected, increasing dilution was associated with an increas-
ing proportion of nondetected transcripts. Nondetection affected
1% of transcripts at 10-fold dilution, 10% at 100-fold dilution, 49%
at 1000-fold dilution, and 62% at 10,000-fold dilution (Fig. 1). Non-
detection was nonrandom, as probes with higher cycle threshold
(CT) values prior to dilution were preferentially not detected
(Supplemental Fig. S1).
We normalized predilution and diluted samples with quantile,
mean, median, and our novel minimum variance methods.
Quantile normalization assumes that the distribution of expression
values itself is invariant; it ranks each sample’s expression values
and then partitions ordered expression values into intervals
(quantiles) [10]. Expression values are then shifted so that the
quantiles from one sample match the quantiles of the reference
sample. Nonrandom nondetection skews quantiles to being less
representative of reference quantiles for higher instances of
nondetection. Because quantile normalization is standard practice
in microarrays, we evaluated the effect of this nonrandom, nonde-
tection skew on our dataset (Fig. 1 and Supplemental Fig. S1). The
quantile method was tested with a bin size of 1% using all
detectable transcripts. Quantiles were then shifted based on the
difference in a given bin’s median compared to the reference med-
ian. Distributions become more divergent for greater nondetection,
making quantile-based approaches less reliable.
Median normalization assumes that the median expression
value should not vary across samples; it shifts each sample’s
distribution of expression values such that all samples end with
the same median expression value. This is equivalent to a simpli-
ﬁed quantile approach that normalizes based on only the 50th per-
centile. Two possible approaches to implementing median
Fig.2. False discovery rates for different data-driven normalization methods. The
false discovery rate is the percentage of transcripts that were signiﬁcantly
differentially expressed after the Benjamini–Hochberg correction for multiple
hypothesis testing. Average nondetection represents the average percentage of
transcripts that were nondetected across the dilution replicates.
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the median of all detected transcripts and (2) the median of only
the transcripts that are detectable in both the reference and the
sample of interest (referred to as shared transcripts). Both of these
methods were chosen to demonstrate the effect that nondetection
has on false discovery rates, and to demonstrate a simple way to
mitigate these effects for moderate amounts of nondetection.
Mean normalization shifts expression based on the geometric
mean for expression values and fold change or the arithmetic mean
for CT values. Mean-based normalization often utilizes correction
factors that account for differences in distributions between a ref-
erence set and a test set, one of which we used for this analysis
[11]. The mean-based approach was calculated using the arithme-
tic mean of CT values and was then corrected for differences in
standard deviation [11] between the undiluted and the diluted
sample. Only shared detected transcripts between the diluted
and the undiluted sample were used in this calculation.
In the above methods, between-sample variability in the pro-
portion of nondetected transcripts could alter the statistical prop-
erty used for normalization, potentially leading to false discovery.
To minimize this bias in normalization due to variability in tran-
script detection, we designed a minimum variance method that
minimizes the between-sample variance in only the shared tran-
scripts. A reference sample is selected and treated as the true dis-
tribution of transcripts. The variance between the reference and a
sample is then calculated using the equation
global variance ¼ Rni ððTi;sample  shiftÞ  Ti;referenceÞ2; ð1Þ
where Ti is the CT value for ith shared transcript and n is the total
number of shared transcripts.
The optimal shift to be used for normalization is the value that
minimizes global variance and thereby makes the overall distribu-
tion of a sample’s expression values as similar to the reference as
possible.
We tested for signiﬁcant differential expression between the
undiluted and the diluted sampleswith unpaired t tests formethods
that used all detectable transcripts and paired t tests for methods
that used shared detectable transcripts. Each dilution replicate
was treated as an independent sample with an undiluted reference
in order to simulate the effect of having independent samples. A
Benjamini–Hochberg multiple testing correction with a 0.05 false
discovery ratewasused to set a threshold for differential expression.
The criterion for determining the validity of a method is a false
discovery rate <0.05 (Fig. 2). For samples with low average nonde-
tection (<10% nondetection), all methods performed well. For sam-
ples with high average nondetection (62% nondetection), no
method had less than a 0.05 false discovery rate after the multiple
testing correction. All paired methods performed adequately well
up to an average nondetection of 49%, with minimum variance
consistently performing the best out of the paired methods. By
contrast, when average nondetection reached 49%, false discovery
rates were 23% with quantile normalization and 30% with unpaired
median normalization, indicating that these methods are inappro-
priate in samples with moderate to high nondetection. The quan-
tile method performed equivalent to or slightly better than the
unpaired median approach across all dilutions, which is expected
given that the median approach is a simpliﬁed quantile approach.
Our dilution series shows that even at a moderate level of non-
detection (50%), normalization techniques that use only the
shared detectable genes do not produce high false discovery rates,
with the minimum variance approach consistently performing the
best. Differential expression testing is still valid for samples with
high nondetection and variable target material due to death of
bacilli, allowing for elucidation of novel biology in clinical samples
with low template material.Acknowledgments
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